Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma (Q84587252)
Jump to navigation
Jump to search
scientific article published on 18 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma |
scientific article published on 18 July 2012 |
Statements
Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma (English)
Darrell White
Adetola Kassim
Birbal Bhaskar
Jing Yi
Karen Wamstad
Virginia E Paton